substituted n- (1h-indazol-4-yl) imidazo [1,2-a] pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

• 收藏
• 分享

专利权人:

ARRAY BIOPHARMA

发明人:

APRIL L. KENNEDY,DAVID A. MARESKA,ERIK JAMES HICKEN,FREDRIK P. MARMSATER,MARK C. MUNSON,MARK LAURENCE BOYS,ROBERT TIRK DELISLE

申请号：

BR112013014854

公开号：

BR112013014854A8

申请日:

2011.12.13

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

Compounds of Formula I: and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/